InsightRX vs PrecisePK (2026)
The two most inspectable dosing platforms in the index, which makes this the closest comparison in the segment. InsightRX runs published population pharmacokinetic models rather than proprietary ones, holds certified Epic marketplace integration and published an analysis of more than 168,000 treatment courses, the nearest thing to post deployment monitoring anyone here offers. PrecisePK holds the best independent comparative result in the category and explains its computation openly, with a sixty day evaluation so a pharmacy can test its own cases. Both let you see the science, which is the point. The separator is institutional: InsightRX publishes the assurance and integration credentials a hospital procurement will ask for, and PrecisePK publishes none of them.
- The population pharmacokinetic models it runs are published rather than proprietary, so a pharmacy can read the science behind the recommendation.
- Certified Epic marketplace integration and a published analysis of more than 168,000 treatment courses, which is the closest thing to post deployment monitoring in the segment.
- Automatic import is limited to the data the dosing calculation needs rather than bulk extraction.
- The best independent comparative result in this category, which no amount of vendor evidence substitutes for.
- The computation is walked through in sequence on the vendor's own site, which is unusually open for a product of this kind.
- A sixty day evaluation is offered, so a pharmacy can test it against its own cases before committing.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. InsightRX and PrecisePK are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | InsightRX | PrecisePK |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Founded | 2015 | Not recorded |
| Headquarters | San Francisco, California, United States | San Diego, California, United States |
| Website | insight-rx.com | precisepk.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards InsightRX its top capability grade on Model and Technology Transparency and EHR and Interoperability Depth. Set against PrecisePK, InsightRX grades higher on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Its thinnest published disclosure sits on Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for PrecisePK on any axis it scores. Set against InsightRX, PrecisePK grades higher on Commercial Transparency. Its thinnest published disclosure sits on HIPAA and BAA Posture, Security Certifications and Trust Center and AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose InsightRX or PrecisePK?
On the axes where the AI Health Index separates them, InsightRX grades higher on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure, and PrecisePK grades higher on Commercial Transparency. InsightRX leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do InsightRX and PrecisePK differ most?
The widest separation the AI Health Index records between InsightRX and PrecisePK is on HIPAA and BAA Posture, where InsightRX grades B and PrecisePK grades D. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do InsightRX and PrecisePK grade the same?
The AI Health Index grades InsightRX and PrecisePK the same on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and FDA and Regulatory Status. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have InsightRX and PrecisePK not disclosed?
At the last review, at least one of InsightRX and PrecisePK published thin or absent detail on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and AI Governance and Bias Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
The independent comparison in this segment included multiple platforms and did not find them equivalent across every drug and scenario, so ask each vendor how it performed for the specific agents your service doses rather than in aggregate. Neither holds a device clearance.
PrecisePK publishes no security attestation, health privacy statement or business associate terms, and neither vendor publishes performance by renal function band, body habitus, age, sex or race, which are the variables that actually move a dose.